{"id":3908,"date":"2013-03-07T20:37:10","date_gmt":"2013-03-07T20:37:10","guid":{"rendered":"http:\/\/www.medicalmarijuanainc.com\/?p=4241"},"modified":"2013-03-07T20:37:10","modified_gmt":"2013-03-07T20:37:10","slug":"kannalife-sciences-announces-1-5m-series-a-financing-from-medical-marijuana-inc-otcmjna-and-cannavest-corp-otcfcls","status":"publish","type":"post","link":"https:\/\/medicalmarijuanainc.com\/2013\/03\/07\/kannalife-sciences-announces-1-5m-series-a-financing-from-medical-marijuana-inc-otcmjna-and-cannavest-corp-otcfcls\/","title":{"rendered":"KannaLife Sciences Announces $1.5M Series A Financing From Medical Marijuana Inc. (OTC:MJNA) And CannaVest Corp. (OTC:FCLS)"},"content":{"rendered":"
\n
\n

NEW YORK, March 7, 2013 \/PRNewswire\/ —\u00a0KannaLife Sciences, Inc. (“KannaLife”) the phyto-medical company that specializes in the research & development of pharmacological products derived from botanical sources, announced today the entry into Series A financing totaling $1.5 million.<\/p>\n

The investment is led by and Medical Marijuana Inc. (OTC: MJNA) and CannaVest Corp. (OTC: FCLS).<\/p>\n